Found: 59
Select item for more details and to access through your institution.
New Insights Into the Regulation of Lipoprotein Metabolism by PCSK9: Lessons From Stable Isotope Tracer Studies in Human Subjects.
- Published in:
- Frontiers in Physiology, 2021, v. 11, p. N.PAG, doi. 10.3389/fphys.2021.603910
- By:
- Publication type:
- Article
Long-Term Efficacy and Safety of Evinacumab in Patients with Homozygous Familial Hypercholesterolemia: Real-World Clinical Experience.
- Published in:
- Pharmaceuticals (14248247), 2022, v. 15, n. 11, p. 1389, doi. 10.3390/ph15111389
- By:
- Publication type:
- Article
Apolipoprotein(a) Kinetics in Statin-Treated Patients With Elevated Plasma Lipoprotein(a) Concentration.
- Published in:
- 2019
- By:
- Publication type:
- journal article
ω-3 Fatty Acid Ethyl Esters Diminish Postprandial Lipemia in Familial Hypercholesterolemia.
- Published in:
- 2016
- By:
- Publication type:
- journal article
Association of Plasma Ceramides and Sphingomyelin With VLDL apoB-100 Fractional Catabolic Rate Before and After Rosuvastatin Treatment.
- Published in:
- 2015
- By:
- Publication type:
- Journal Article
Dose-dependent effects of rosuvastatin on the plasma sphingolipidome and phospholipidome in the metabolic syndrome.
- Published in:
- 2014
- By:
- Publication type:
- Journal Article
Effect of [omega]-3 Fatty Acid Ethyl Esters on Apolipoprotein B-48 Kinetics in Obese Subjects on a Weight-Loss Diet: A New Tracer Kinetic Study in the Postprandial State.
- Published in:
- 2014
- By:
- Publication type:
- Journal Article
Plasma apolipoprotein B-48 transport in obese men: a new tracer kinetic study in the postprandial state.
- Published in:
- 2014
- By:
- Publication type:
- Journal Article
Mechanism of Action of a Peroxisome Proliferator-Activated Receptor (PPAR)-δ Agonist on Lipoprotein Metabolism in Dyslipidemic Subjects with Central Obesity.
- Published in:
- Journal of Clinical Endocrinology & Metabolism, 2011, v. 96, n. 10, p. 1568, doi. 10.1210/jc.2011-1131
- By:
- Publication type:
- Article
ANGPTL3 as a therapeutic target for treating homozygous familial hypercholesterolaemia: a shot in the arm for evinacumab.
- Published in:
- European Heart Journal, 2024, v. 45, n. 27, p. 2435, doi. 10.1093/eurheartj/ehae321
- By:
- Publication type:
- Article
The Knowns and Unknowns of Contemporary Statin Therapy for Familial Hypercholesterolemia.
- Published in:
- Current Atherosclerosis Reports, 2020, v. 22, n. 11, p. 1, doi. 10.1007/s11883-020-00884-2
- By:
- Publication type:
- Article
Very Low Density Lipoprotein Metabolism and Plasma Adiponectin as Predictors of High-Density Lipoprotein Apolipoprotein A-I Kinetics in Obese and Nonobese Men.
- Published in:
- Journal of Clinical Endocrinology & Metabolism, 2009, v. 94, n. 3, p. 989, doi. 10.1210/jc.2008-1457
- By:
- Publication type:
- Article
Plasma apolipoprotein C-III transport in centrally obese men: associations with very low-density lipoprotein apolipoprotein B and high-density lipoprotein apolipoprotein A-I metabolism.
- Published in:
- 2008
- By:
- Publication type:
- journal article
High-Density Lipoprotein (HDL) Transport in the Metabolic Syndrome: Application of a New Model for HDL Particle Kinetics.
- Published in:
- Journal of Clinical Endocrinology & Metabolism, 2006, v. 91, n. 3, p. 973, doi. 10.1210/jc.2005-1895
- By:
- Publication type:
- Article
Mechanism of Action of a 3-Hydroxy-3-Methylglutaryl Coenzyme A Reductase Inhibitor on Apolipoprotein B-100 Kinetics in Visceral Obesity.
- Published in:
- Journal of Clinical Endocrinology & Metabolism, 2000, v. 85, n. 5, p. 2283
- By:
- Publication type:
- Article
Pituitary-Adrenal Suppression and Recovery in Preterm Very Low Birth Weight Infants after Dexamethasone Treatment for Bronchopulmonary Dysplasia.
- Published in:
- Journal of Clinical Endocrinology & Metabolism, 1997, v. 82, n. 8, p. 2429, doi. 10.1210/jcem.82.8.4152
- By:
- Publication type:
- Article
Lipoprotein(a) Is Associated with Thrombus Burden in Culprit Arteries of Younger Patients with ST-Segment Elevation Myocardial Infarction.
- Published in:
- Cardiology, 2023, v. 148, n. 2, p. 98, doi. 10.1159/000529600
- By:
- Publication type:
- Article
Inter-relationships between proprotein convertase subtilisin/kexin type 9, apolipoprotein C-III and plasma apolipoprotein B-48 transport in obese subjects: a stable isotope study in the postprandial state.
- Published in:
- Clinical Science, 2015, v. 128, n. 6, p. 379, doi. 10.1042/CS20140559
- By:
- Publication type:
- Article
Omega-3 fatty acid ethyl ester supplementation decreases very-low-density lipoprotein triacylglycerol secretion in obese men.
- Published in:
- Clinical Science, 2013, v. 125, n. 1, p. 45, doi. 10.1042/CS20120587
- By:
- Publication type:
- Article
An Analysis of the Gut Microbiota and Related Metabolites following PCSK9 Inhibition in Statin-Treated Patients with Elevated Levels of Lipoprotein(a).
- Published in:
- Microorganisms, 2024, v. 12, n. 1, p. 170, doi. 10.3390/microorganisms12010170
- By:
- Publication type:
- Article
RNA interference therapy for targeting ANGPTL3 and atherogenic lipoproteins: Findings and implications of a recent phase I study.
- Published in:
- Clinical & Translational Medicine, 2023, v. 13, n. 11, p. 1, doi. 10.1002/ctm2.1484
- By:
- Publication type:
- Article
Plasma lipoprotein(a) is associated with calcification activity of the thoracic aorta and aortic valve in statin naïve individuals with diabetes mellitus.
- Published in:
- European Journal of Clinical Investigation, 2024, v. 54, n. 5, p. 1, doi. 10.1111/eci.14167
- By:
- Publication type:
- Article
Does fish oil supplementation increase cholesterol efflux capacity in familial hypercholesterolaemia?
- Published in:
- European Journal of Clinical Investigation, 2023, v. 53, n. 10, p. 1, doi. 10.1111/eci.14048
- By:
- Publication type:
- Article
Effect of a PCSK9 inhibitor and a statin on cholesterol efflux capacity: A limitation of current cholesterol‐lowering treatments?
- Published in:
- European Journal of Clinical Investigation, 2022, v. 52, n. 7, p. 1, doi. 10.1111/eci.13766
- By:
- Publication type:
- Article
Effect of Lipoprotein(a) on the Diagnosis of Familial Hypercholesterolemia: Does It Make a Difference in the Clinic?
- Published in:
- Clinical Chemistry, 2019, v. 65, n. 10, p. 1258, doi. 10.1373/clinchem.2019.306738
- By:
- Publication type:
- Article
PCSK9 inhibition with alirocumab decreases plasma lipoprotein(a) concentration by a dual mechanism of action in statin‐treated patients with very high apolipoprotein(a) concentration.
- Published in:
- Journal of Internal Medicine, 2022, v. 291, n. 6, p. 870, doi. 10.1111/joim.13457
- By:
- Publication type:
- Article
Therapeutic inhibition of angiopoietin-like protein 3 for hypertriglyceridaemia and residual risk of ASCVD: beginning of the end or end of the beginning?
- Published in:
- European Journal of Preventive Cardiology, 2024, v. 31, n. 10, p. 1224, doi. 10.1093/eurjpc/zwae095
- By:
- Publication type:
- Article
A genetic risk score predicts coronary artery disease in familial hypercholesterolaemia: enhancing the precision of risk assessment.
- Published in:
- Clinical Genetics, 2020, v. 97, n. 2, p. 257, doi. 10.1111/cge.13648
- By:
- Publication type:
- Article
Effectiveness of proprotein convertase subtilisin/kexin‐9 monoclonal antibody treatment on plasma lipoprotein(a) concentrations in patients with elevated lipoprotein(a) attending a clinic.
- Published in:
- Clinical Cardiology, 2021, v. 44, n. 6, p. 805, doi. 10.1002/clc.23607
- By:
- Publication type:
- Article
Association of Serum Lipoprotein (a) With the Requirement for a Peripheral Artery Operation and the Incidence of Major Adverse Cardiovascular Events in People With Peripheral Artery Disease.
- Published in:
- 2020
- By:
- Publication type:
- journal article
Lipoprotein(a) Particle Production as a Determinant of Plasma Lipoprotein(a) Concentration Across Varying Apolipoprotein(a) Isoform Sizes and Background Cholesterol-Lowering Therapy.
- Published in:
- 2019
- By:
- Publication type:
- journal article
Menopausal Status and Abdominal Obesity Are Significant Determinants of Hepatic Lipid Metabolism in Women.
- Published in:
- 2015
- By:
- Publication type:
- journal article
Lipoprotein (a) and Low‐density lipoprotein apolipoprotein B metabolism following apheresis in patients with elevated lipoprotein(a) and coronary artery disease.
- Published in:
- European Journal of Clinical Investigation, 2019, v. 49, n. 2, p. N.PAG, doi. 10.1111/eci.13053
- By:
- Publication type:
- Article
Triglyceride-rich lipoprotein metabolism in women: roles of apoC- II and apoC- III.
- Published in:
- European Journal of Clinical Investigation, 2016, v. 46, n. 8, p. 730, doi. 10.1111/eci.12657
- By:
- Publication type:
- Article
Short-term Efficacy and Tolerability of Combination Therapy with Lovastatin and Acipimox in Chinese Patients with Type 2 Diabetes Mellitus and Mixed Dyslipidemia.
- Published in:
- 1998
- By:
- Publication type:
- Other
Adipocytokines and VLDL metabolism: independent regulatory effects of adiponectin, insulin resistance, and fat compartments on VLDL apolipoprotein B-100 kinetics?
- Published in:
- 2005
- By:
- Publication type:
- journal article
Adipocytokines and VLDL Metabolism.
- Published in:
- Diabetes, 2005, v. 54, n. 3, p. 795
- By:
- Publication type:
- Article
Differential regulation of lipoprotein kinetics by atorvastatin and fenofibrate in subjects with the metabolic syndrome.
- Published in:
- 2003
- By:
- Publication type:
- journal article
Regulatory effects of HMG CoA reductase inhibitor and fish oils on apolipoprotein B-100 kinetics in insulin-resistant obese male subjects with dyslipidemia.
- Published in:
- 2002
- By:
- Publication type:
- journal article
Familial Hypercholesterolemia and Elevated Lipoprotein(a): Cascade Testing and Other Implications for Contextual Models of Care.
- Published in:
- Frontiers in Genetics, 2022, v. 13, p. 1, doi. 10.3389/fgene.2022.905941
- By:
- Publication type:
- Article
Is type 2 diabetes associated dementia a microvascular early-Alzheimer's phenotype induced by aberrations in the peripheral metabolism of lipoprotein-amyloid?
- Published in:
- Frontiers in Endocrinology, 2023, v. 14, p. 1, doi. 10.3389/fendo.2023.1127481
- By:
- Publication type:
- Article
A Comparative Analysis of Phenotypic Predictors of Mutations in Familial Hypercholesterolemia.
- Published in:
- 2018
- By:
- Publication type:
- journal article
Dietary plant sterols supplementation does not alter lipoprotein kinetics in men with the metabolic syndrome.
- Published in:
- Asia Pacific Journal of Clinical Nutrition, 2007, v. 16, n. 4, p. 624
- By:
- Publication type:
- Article
Cost impact of undertaking detection and management of familial hypercholesterolaemia in Australian general practice.
- Published in:
- Australian Journal of General Practice, 2022, v. 51, n. 8, p. 604
- By:
- Publication type:
- Article
Awareness of familial hypercholesterolaemia in Australian primary care: A qualitative descriptive study.
- Published in:
- Australian Journal of General Practice, 2021, v. 50, n. 9, p. 634, doi. 10.31128/ajgp-04-21-5952
- By:
- Publication type:
- Article
Implications of new clinical practice guidance on familial hypercholesterolaemia for Australian general practitioners.
- Published in:
- Australian Journal of General Practice, 2021, v. 50, n. 9, p. 616, doi. 10.31128/ajgp-02-21-5836
- By:
- Publication type:
- Article
High-density Lipoprotein Apolipoprotein A-I Kinetics in Obesity<sup>**</sup>.
- Published in:
- Obesity (19307381), 2005, v. 13, n. 6, p. 1008, doi. 10.1038/oby.2005.118
- By:
- Publication type:
- Article
Plasma Markers of Cholesterol Homeostasis and Apolipoprotein B-100 Kinetics in the Metabolic Syndrome.
- Published in:
- Obesity (19307381), 2003, v. 11, n. 4, p. 591, doi. 10.1038/oby.2003.83
- By:
- Publication type:
- Article
Fat Compartments and Apolipoprotein B-100 Kinetics in Overweight-Obese Men.
- Published in:
- Obesity (19307381), 2003, v. 11, n. 1, p. 152, doi. 10.1038/oby.2003.24
- By:
- Publication type:
- Article
Controlled study of the effect of proprotein convertase subtilisin-kexin type 9 inhibition with evolocumab on lipoprotein(a) particle kinetics.
- Published in:
- European Heart Journal, 2018, v. 39, n. 27, p. 2577, doi. 10.1093/eurheartj/ehy122
- By:
- Publication type:
- Article